Citation: Ra. Hamilton et al., FREQUENCY OF HOSPITALIZATION AFTER EXPOSURE TO KNOWN DRUG-DRUG INTERACTIONS IN A MEDICAID POPULATION, Pharmacotherapy, 18(5), 1998, pp. 1112-1120
Citation: Ll. Briceland et Ra. Hamilton, ASSESSMENT OF FACTORS WHICH INFLUENCE PHARMD CLERKSHIP GRADES, American journal of pharmaceutical education, 61(2), 1997, pp. 157-160
Citation: Mw. Griswold et al., QUINUPRISTIN-DALFOPRISTIN (RP-59500) - AN INJECTABLE STREPTOGRAMIN COMBINATION, American journal of health-system pharmacy, 53(17), 1996, pp. 2045-2053
Authors:
AMODIOGROTON M
MADU A
MADU CN
BRICELAND LL
SELIGMAN M
MCMASTER P
MILLER MH
Citation: M. Amodiogroton et al., SEQUENTIAL PARENTERAL AND ORAL CIPROFLOXACIN REGIMEN VERSUS PARENTERAL THERAPY FOR BACTEREMIA - A PHARMACOECONOMIC ANALYSIS, The Annals of pharmacotherapy, 30(6), 1996, pp. 596-602
Citation: Ts. Lesar et Ll. Briceland, SURVEY OF ANTIBIOTIC CONTROL POLICIES IN UNIVERSITY-AFFILIATED TEACHING INSTITUTIONS, The Annals of pharmacotherapy, 30(1), 1996, pp. 31-34
Citation: Sl. Preston et Ll. Briceland, FLUCONAZOLE FOR ANTIFUNGAL PROPHYLAXIS IN CHEMOTHERAPY-INDUCED NEUTROPENIA, American journal of health-system pharmacy, 52(2), 1995, pp. 164-173
Citation: Sl. Preston et al., DOSING ADJUSTMENT OF 10 ANTIMICROBIALS FOR PATIENTS WITH RENAL IMPAIRMENT, The Annals of pharmacotherapy, 29(12), 1995, pp. 1202-1207
Citation: Lm. Cira et al., PITFALLS OF USING ANTIMICROBIAL ORDER FORMS TO EVALUATE DRUG-USE, American journal of hospital pharmacy, 51(5), 1994, pp. 700-703
Citation: Sl. Preston et Ll. Briceland, INTRATHECAL ADMINISTRATION OF AMIKACIN FOR TREATMENT OF MENINGITIS SECONDARY TO CEPHALOSPORIN-RESISTANT ESCHERICHIA-COLI, The Annals of pharmacotherapy, 27(7-8), 1993, pp. 870-873
Citation: Mp. Kane et al., SOLVING DRUG-RELATED PROBLEMS IN THE PROFESSIONAL EXPERIENCE PROGRAM, American journal of pharmaceutical education, 57(4), 1993, pp. 347-351